There is an exciting new player in the ever-expanding field of genome editing. In a study reported in the January 2013 issue of Science, two groups—Cong et al.1 and Mali et al.2—explored the limits and adaptability of a prokaryotic RNA-based system for mammalian genome-wide editing. This new method of genome engineering is derived from an adaptive immune system known as CRISPR (Clustered Regulatory Interspaced Short Palindromic Repeats) that bacteria and archaea use as a means to protect themselves against foreign invasive elements.
No takes yet. Share an insight, caveat, or question.
Damian et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: